Abstract B196: Intratumoral administration of IMO-2125, a novel TLR9 agonist, modulates tumor microenvironment and potentiates antitumor activity of anti-PD-1 mAb in a murine colon carcinoma model
Keyword(s):
2020 ◽
Vol 16
◽
pp. 158-171
◽
Keyword(s):
2017 ◽
Vol 18
(8)
◽
pp. 616-626
◽
2003 ◽
Vol 105
(6)
◽
pp. 820-824
◽
Keyword(s):
Keyword(s):
Keyword(s):
2004 ◽
Vol 10
(13)
◽
pp. 4498-4508
◽
Keyword(s):